Basecamp Research key facts
as of Oct 2026- Developer of a biological-design platform designed to explore and recreate the full complexity of natural biodiversity.
- Basecamp Research is valued at approximately $800.0M as of Oct 2026, set at its Series C, Sep 2026; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $84.3M across 1 recorded rounds; the latest was Series C ($140.0M) in Sep 2026.
- Notable investors include Microsoft for Startups, Menlo Ventures, True Ventures, Catalio Capital Management, S32 — 20 tracked in total.
- Status: Privately Held (backing).
Valued at $800.0M at its Series C, Sep 2026. Nothing has traded since.
- ·The post-money valuation on its round
- ·The complete investor list: 20 names
- ·Watch Basecamp Research: the Monday email on marks, rounds and moves
Basecamp Research funding rounds
1 roundsWho backs Basecamp Research
20+Basecamp Research valuation
Basecamp Research was valued at $800 million at its Series C in Sep 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
Recent activity
In the last 90 days, Basecamp Research's record added 1 funding round.
How much has Basecamp Research raised?
Basecamp Research has raised $84.3 million across 1 recorded round since 2026. The largest was a $140 million Series C in Sep 2026. 1 of the rounds disclosed a post-money valuation.
Basecamp Research investors
20 investors are on record for Basecamp Research, including Microsoft for Startups, Menlo Ventures, True Ventures and Catalio Capital Management. By type, the record holds 9 venture capital firms and 1 family office. The Series C in Sep 2026 drew 16 investors.
About Basecamp Research
Developer of a biological-design platform designed to explore and recreate the full complexity of natural biodiversity. The company's platform uses a massive, ethically-sourced biological knowledge graph and AI-driven tools to map biodiversity at scale, reconstruct multiple novel protein sequences, model full biological context, and design new proteins and genomes, enabling research and biotech organizations to develop novel therapeutics, food, agriculture, and other biologically-derived products with innovation and potential beyond traditional methods.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 48
- Website
- basecamp-research.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.